ischemic heart conditions
diagnostic device
ischemic preconditioning
specific heart diseases
AnandaCor
active pharmaceutical ingredient
API targets
Ananda Pharma GmbH
myocardial cell
new diagnostic medical device
effective diagnostic investigation
small vessels
large vessels
fast melting tablet
innovative tablet formulation
energy metabolism of cardiomyocytes
specific mode of action
angina pectoris
patients
plant
larger therapeutic range
relevant obstructive coronary atherosclerosis
actual ischemia
smaller risk
great potential
balancing effect
effects
feasibility assessment
urgent need
deaths
microvasculature
turnover of lactate
year
external costs
similar substances
industrialized countries
Concept
European Union
annum
properties
nanomolar
ATPase